11/21
08:38 am
cdtx
Cidara Therapeutics Announces $105 Million Private Placement [Yahoo! Finance]
Medium
Report
Cidara Therapeutics Announces $105 Million Private Placement [Yahoo! Finance]
11/21
08:30 am
cdtx
Cidara Therapeutics Announces $105 Million Private Placement
High
Report
Cidara Therapeutics Announces $105 Million Private Placement
11/19
08:08 am
cdtx
Cidara Therapeutics to Participate in Evercore 7th Annual HealthCONx Conference [Yahoo! Finance]
Medium
Report
Cidara Therapeutics to Participate in Evercore 7th Annual HealthCONx Conference [Yahoo! Finance]
11/19
08:00 am
cdtx
Cidara Therapeutics to Participate in Evercore 7th Annual HealthCONx Conference
Medium
Report
Cidara Therapeutics to Participate in Evercore 7th Annual HealthCONx Conference
11/11
11:15 pm
cdtx
Cidara Therapeutics, Inc. (NASDAQ: CDTX) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Low
Report
Cidara Therapeutics, Inc. (NASDAQ: CDTX) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
11/11
11:15 pm
cdtx
Cidara Therapeutics, Inc. (NASDAQ: CDTX) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Low
Report
Cidara Therapeutics, Inc. (NASDAQ: CDTX) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
11/11
08:09 am
cdtx
Cidara Therapeutics, Inc. (NASDAQ: CDTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $24.00 price target on the stock.
Low
Report
Cidara Therapeutics, Inc. (NASDAQ: CDTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $24.00 price target on the stock.
11/7
06:21 pm
cdtx
Cidara Therapeutics GAAP EPS of -$2.38 beats by $1.87 [Seeking Alpha]
Medium
Report
Cidara Therapeutics GAAP EPS of -$2.38 beats by $1.87 [Seeking Alpha]
11/7/2024
04:15 pm
CDTX
cidara therapeutics, inc.
BEAT
Report
3.0%
cidara therapeutics, inc.
8/13/2024
04:29 pm
CDTX
cidara therapeutics, inc.
BEAT
Report
5.8%
cidara therapeutics, inc.
5/15/2024
04:09 pm
CDTX
cidara therapeutics, inc.
MISS
Report
-6.4%
cidara therapeutics, inc.
11/14
04:23 pm
cdtx
Form SC 13G/A Cidara Therapeutics, Filed by: BIOTECHNOLOGY VALUE FUND L P
Low
Report
Form SC 13G/A Cidara Therapeutics, Filed by: BIOTECHNOLOGY VALUE FUND L P
11/7
04:22 pm
cdtx
Form 8-K Cidara Therapeutics, For: Nov 07
Low
Report
Form 8-K Cidara Therapeutics, For: Nov 07
11/7
04:11 pm
cdtx
Form 10-Q Cidara Therapeutics, For: Sep 30
Low
Report
Form 10-Q Cidara Therapeutics, For: Sep 30
10/2
05:30 pm
cdtx
Form 4 Cidara Therapeutics, For: Sep 30 Filed by: Sandison Taylor
Low
Report
Form 4 Cidara Therapeutics, For: Sep 30 Filed by: Sandison Taylor
10/2
05:28 pm
cdtx
Form 4 Cidara Therapeutics, For: Sep 30 Filed by: Tari Leslie
Low
Report
Form 4 Cidara Therapeutics, For: Sep 30 Filed by: Tari Leslie
10/2
05:25 pm
cdtx
Form 4 Cidara Therapeutics, For: Sep 30 Filed by: Stein Jeffrey
Low
Report
Form 4 Cidara Therapeutics, For: Sep 30 Filed by: Stein Jeffrey
10/2
05:19 pm
cdtx
Form 4 Cidara Therapeutics, For: Sep 30 Filed by: Shah Preetam
Low
Report
Form 4 Cidara Therapeutics, For: Sep 30 Filed by: Shah Preetam
10/2
05:18 pm
cdtx
Form 4 Cidara Therapeutics, For: Sep 30 Filed by: Ward Shane
Low
Report
Form 4 Cidara Therapeutics, For: Sep 30 Filed by: Ward Shane
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
9/3
Thinking about buying stock in Cidara Therapeutics, Canopy Growth, Generac, Lowe's, or Medicines Co?
-22.6%
7/29
Form 8-K Cidara Therapeutics, For: Jul 29
-14.7%
9/3
Cidara Therapeutics Inc (NASDAQ: CDTX) was upgraded by analysts at Wedbush from a "neutral" rating to an "outperform" rating.
-13.5%
1/13
Form 8-K Cidara Therapeutics, For: Jan 13
-10.8%
4/7
Cidara Therapeutics to Present at the 19th Annual Needham Virtual Healthcare Conference
-7.8%
2/21
Form SC 13G Cidara Therapeutics, Filed by: Stonepine Capital Management, LLC
-7.4%
1/10
Cidara Therapeutics Announces Proposed Rights Offering
-6.7%
7/29
Form 8-K Cidara Therapeutics, For: Jul 29
-6.1%
4/28
Cidara Therapeutics to Participate in Antifungal and COVID-19 Therapeutics Panels at Maxim Group’s Infectious Disease Virtual Conference
-6.0%
10/1
Form 4 Cidara Therapeutics, For: Sep 27 Filed by: Oien Jessica
-5.9%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register